Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
olaparib
×
Gastrointestinal
×
Clear all
Filters
3
NCT04456699
2024-10-29
LYNK-003
Merck Sharp & Dohme LLC
Phase 3
Completed
335 enrolled
19 charts
NCT02184195
2023-09-13
POLO
AstraZeneca
Phase 3
Completed
154 enrolled
20 charts
1 FDA